VIRTUAL SCREENING AND MOLECULAR DOCKING OF NDM1 INHIBITOR FOR TREATMENT OF KLEBSIELLA PNEUMONIA INFECTION

Life Sciences-Bioinformatics

Authors

  • C.THIYAGARAJAN Department of Biotechnology, Srimad Andavan Arts and Science College (Autonomous), No-7, Nelson Road Trichy, Tamilnadu, India
  • P.THIRUMALAIVASAN Department of Biotechnology, Srimad Andavan Arts and Science College (Autonomous), No-7, Nelson Road Trichy, Tamilnadu, India

Keywords:

NDM1, Antibiotics resistance, Docking, Virtual screening, ADMET.

Abstract

The outbreak of antimicrobial resistance has become one of the most serious public health problems across in the world. The search for promising antimicrobial inhibitors is still under limelight as bacteria are continuously developing resistance to antimicrobial compounds. The Metallo-β-lactamases (MβLs) is  one the New Delhi metallo‐beta‐lactamase 1  (NDM-1) are principle contributors of the emergence of resistance to their ability to hydrolyze almost all known β-lactam antibiotics including penicillins, cephalosporins, and carbapenems. In this study, we used the computer assisted methodology such as virtual screening and molecular docking studies to apply and identify six potent inhibitors against NDM1.

Published

2022-06-17

How to Cite

C.THIYAGARAJAN, & P.THIRUMALAIVASAN. (2022). VIRTUAL SCREENING AND MOLECULAR DOCKING OF NDM1 INHIBITOR FOR TREATMENT OF KLEBSIELLA PNEUMONIA INFECTION: Life Sciences-Bioinformatics. International Journal of Life Science and Pharma Research, 6(1), 51–58. Retrieved from https://www.ijlpr.com/index.php/journal/article/view/359

Issue

Section

Research Articles